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A myosin for RNA Pol II
T
ranscription gets a boost from myosin 
VI, according to fi  ndings from Sarah 
Vreugde (DIBIT Scientifi  c  Institute, 
Milano, Italy) and colleagues. The motor might 
drag genes into transcription neighborhoods.
While trying to understand the function of 
myosin VI, Vreugde noticed that its localization 
pattern looked much like that of RNA polymer-
ase II. The authors then showed an association 
between the motor and polymerase that depends 
on ongoing transcription.
By cross-linking myosin VI to chromatin, 
the group identifi  ed several genes at which the 
motor is found. The mRNA levels of these genes 
decreased when myosin VI levels were reduced. 
Vreugde next hopes to inhibit just the nuclear 
pool of myosin VI and then do genome-wide 
analyses to identify more affected genes.
Assuming its infl  uence is widespread, the mo-
tor might spool the DNA past aggregates of RNA 
polymerases or recruit stretches of DNA to tran-
scription factories. “DNA recruitment to transcrip-
tion factories would be heavy work,” says Vreugde. 
“But myosin is well-suited to accomplish that.”
Whether its unusual preference to move 
toward actin minus ends helps myosin VI at all 
is unclear, as the polarity of the nuclear actin 
network is not known and probably dynamic. 
The only other known nuclear myosin, myosin 
I, is plus-end directed but still enhances tran-
scription by all the RNA polymerases.
Reference: Vreugde, S., et al. 2006. Mol. Cell. 
23:749–755.
T cells told to keep rolling
A 
T cell coreceptor keeps T cells moving so that they are not 
overactivated, according to Helga Schneider, Christopher Rudd 
(University of Cambridge, UK), and colleagues. By not lingering 
too long, killer T cells might be at their most effi  cient.
Rudd’s group recently found that this coreceptor, called CTLA-4, was 
needed for integrin activation. Integrins go hand-in-hand with cell migration, 
which the authors now show is increased by CTLA-4 engagement.
When T cells meet the right antigen-presenting cell (APC), they 
normally stop and interact with the APC to get activated. This stopping 
phase, the authors show, is limited by CTLA-4, which is found on all 
activated T cells and binds to ligands on the APC.
By restricting the interaction time, CTLA-4 may prevent responses to 
low-affi  nity self-antigens that cause autoimmunity. This idea is supported 
by the severe autoimmunity found in mice lacking CTLA-4. Rudd 
suspects that their T cells “park next to an APC for so long that they start 
accumulating signals against self-antigens.”
The anti–stop signal might have been designed to make cytotoxic T cells 
more effi  cient in killing infected or cancerous cells. It might also explain 
why anti–CTLA-4 antibodies succeed as cancer therapies, if they act as 
ligand mimics. “The release of [cytotoxic] granzymes is relatively quick,” 
says Rudd. “The T cell can kill the tumor target cell and not stick around any 
longer than it needs to, take off again and encounter another target.”
Reference: Schneider, H., et al. 2006. Science. doi:10.1126/science.1131078.
Stomata fight infection
P
lants close up shop to prevent pathogen entry. Maeli Melotto, 
Sheng Yang He, and colleagues (Michigan State University, East 
Lansing, MI) show that stomata shut when bacteria are near.
Stomata are the plant’s version of a window—an opening in the 
leaf epidermis where photosynthetic gas exchange occurs. This pore is 
a perfect way in for bacteria, which cannot themselves penetrate the 
epidermis. But the new ﬁ  ndings show that, upon sensing bacterial proteins, 
the two guard cells that form the pore close the window.
Closure depends on signaling pathways activated by plant hormones, 
including salicylic acid and abscisic acid. A bacterial strain that suc-
cessfully invades Arabidopsis overrides the closure and reopens stomata. 
This bypass requires a bacterial compound called coronatine, which 
antagonizes salicylic acid and abscisic acid, possibly by mimicking an-
other hormone, called jasmonic acid.
Other successful bacteria lack coronatine. They might use other tricks 
to reopen stomata or wait around on the surface for heavy rain, which 
opens the pores for them.
Defensive stomatal 
shutting has been over-
looked because most plant 
pathogen researchers de-
liver bacteria directly below 
the epidermis—a “quick 
and easy” laboratory tech-
nique, according to He. But 
he believes that surface inoculations, a more natural state, will become 
more common now that this plant line of defense has been identiﬁ  ed.
Reference: Melotto, M., et al. 2006. Cell. 126:969–980.
An epidermal peel shows that bacteria (green) 
that make coronatine (left) make it through stomata.
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The association (top) of myosin VI (green) and RNA 
polymerase II (red) is lost when transcription is 
disrupted (bottom).
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